Brad Schwartz, MD
Brad Schwartz is Chief Executive Officer of the Morgridge Institute for Research, a private, nonprofit research institute dedicated to interdisciplinary biomedical research in partnership with the University of Wisconsin-Madison. Dr. Schwartz is a physician-scientist whose research and clinical activities focus on hemostasis, and who has a deep commitment to the mission of public research universities.
Ahlquist, a Howard Hughes Medical Institute Investigator and professor of oncology, molecular virology and plant pathology, directs the Morgridge virology team.
Eliceiri, director of the UW-Madison Laboratory for Computational and Optical Instrumentation, is a principal investigator in medical engineering.
Gitter is a UW-Madison assistant professor of biostatistics and medical informatics and Morgridge Institute investigator in virology.
Huisken, a professor of biomedical engineering, directs the Morgridge medical engineering team.
Livny is Chief Technology Officer of the Morgridge Institute and the Wisconsin Institute for Discovery, and also directs core computational technology for research.
Newmark, a Howard Hughes Medical Institute Investigator and professor of zoology, is a principal investigator and the Burnell R. Roberts Chair in Regenerative Biology at the Morgridge Institute.
Ossorio, professor of law and bioethics at UW–Madison, serves as the inaugural Morgridge Bioethics Scholar-in-Residence.
Pagliarini, an associate professor of biochemistry and expert on mitochondria composition and function, directs the Morgridge metabolism team.
Skala is a principal investigator in medical engineering and professor of biomedical engineering at UW-Madison.
Stewart runs a team of talented bioinformaticians and computational biologists who create and utilize sophisticated algorithms for analyzing high-throughput biological data.
Thomson, the John D. MacArthur Professor in UW-Madison medicine and public health and pioneer in stem cell science, directs regenerative biology.